TRT Restores Nail Integrity in Hypogonadal U.S. Males: TANHE Cohort Findings
Reading Time: < 1 minuteIntroduction Testosterone replacement therapy (TRT) has surged in popularity among American males, particularly those aged 40 and older, amid rising diagnoses of hypogonadism. According to the Centers for Disease Control and Prevention (CDC), approximately 2.4 million U.S. men over 40 exhibit symptomatic low testosterone levels, often linked to obesity, metabolic syndrome, and sedentary lifestyles prevalent in the population. While TRT... Read more »
